1. Home
  2. CDXC vs ACCO Comparison

CDXC vs ACCO Comparison

Compare CDXC & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXC
  • ACCO
  • Stock Information
  • Founded
  • CDXC 1999
  • ACCO 1893
  • Country
  • CDXC United States
  • ACCO United States
  • Employees
  • CDXC N/A
  • ACCO N/A
  • Industry
  • CDXC Medicinal Chemicals and Botanical Products
  • ACCO Publishing
  • Sector
  • CDXC Health Care
  • ACCO Consumer Discretionary
  • Exchange
  • CDXC Nasdaq
  • ACCO Nasdaq
  • Market Cap
  • CDXC 449.5M
  • ACCO 487.6M
  • IPO Year
  • CDXC N/A
  • ACCO N/A
  • Fundamental
  • Price
  • CDXC $5.70
  • ACCO $5.16
  • Analyst Decision
  • CDXC Strong Buy
  • ACCO Buy
  • Analyst Count
  • CDXC 2
  • ACCO 1
  • Target Price
  • CDXC $8.00
  • ACCO $7.50
  • AVG Volume (30 Days)
  • CDXC 341.1K
  • ACCO 591.1K
  • Earning Date
  • CDXC 03-05-2025
  • ACCO 02-20-2025
  • Dividend Yield
  • CDXC N/A
  • ACCO 5.83%
  • EPS Growth
  • CDXC N/A
  • ACCO N/A
  • EPS
  • CDXC 0.02
  • ACCO N/A
  • Revenue
  • CDXC $91,668,000.00
  • ACCO $1,706,700,000.00
  • Revenue This Year
  • CDXC $18.64
  • ACCO N/A
  • Revenue Next Year
  • CDXC $20.72
  • ACCO $0.70
  • P/E Ratio
  • CDXC $280.54
  • ACCO N/A
  • Revenue Growth
  • CDXC 9.95
  • ACCO N/A
  • 52 Week Low
  • CDXC $1.46
  • ACCO $4.37
  • 52 Week High
  • CDXC $7.97
  • ACCO $6.62
  • Technical
  • Relative Strength Index (RSI)
  • CDXC 47.71
  • ACCO 43.21
  • Support Level
  • CDXC $5.60
  • ACCO $5.20
  • Resistance Level
  • CDXC $6.08
  • ACCO $5.42
  • Average True Range (ATR)
  • CDXC 0.27
  • ACCO 0.13
  • MACD
  • CDXC -0.01
  • ACCO 0.01
  • Stochastic Oscillator
  • CDXC 28.75
  • ACCO 28.95

About CDXC ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. It offers its products under the AT-A-GLANCE, Five Star, GBC, Hilroy, Kensington, Quartet, Leitz, NOBO and other brands. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands North America segment.

Share on Social Networks: